HK1258712A1 - 抗衰老药物制剂 - Google Patents

抗衰老药物制剂 Download PDF

Info

Publication number: HK1258712A1
Authority: HK; Hong Kong
Prior art keywords: liquid; vessel; production method; containment means; cellular constituents
Prior art date: 2016-08-17

Application number

HK19101113.9A

Other languages

English (en)

Inventor

Peter Wehling

Julio Reinecke

Original Assignee

Orthogen Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2016-08-17

Filing date

2017-05-11

Publication date

2019-11-15

2016-11-14 Priority claimed from PCT/EP2016/001888 external-priority patent/WO2017080669A1/en

2017-05-11 Application filed by Orthogen Ag filed Critical Orthogen Ag

2019-11-15 Publication of HK1258712A1 publication Critical patent/HK1258712A1/zh

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Cell Biology (AREA)
Immunology (AREA)
Biotechnology (AREA)
Developmental Biology & Embryology (AREA)
Virology (AREA)
Zoology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Dermatology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Ophthalmology & Optometry (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Dispersion Chemistry (AREA)
Endocrinology (AREA)
Transplantation (AREA)

HK19101113.9A 2016-08-17 2017-05-11 抗衰老药物制剂 HK1258712A1 (zh)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
EP16001807		2016-08-17
EP16001807.3		2016-08-17
PCT/EP2016/001888 WO2017080669A1 (en)	2015-11-13	2016-11-14	Pharmaceutical preparation effective in age-related disorders
PCT/EP2016/001887 WO2017080668A1 (en)	2015-11-13	2016-11-14	Pharmaceutical preparation effective in age-related disorders
EPPCT/EP2016/001887		2016-11-14
EPPCT/EP2016/001888		2016-11-14
PCT/EP2017/000574 WO2018033226A1 (en)	2016-08-17	2017-05-11	Anti-ageing pharmaceutical preparation

Publications (1)

Publication Number	Publication Date
HK1258712A1 true HK1258712A1 (zh)	2019-11-15

Family

ID=61196401

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
HK19101113.9A HK1258712A1 (zh)	2016-08-17	2017-05-11	抗衰老药物制剂
HK18114754.7A HK1255619A1 (zh)	2016-08-17	2017-05-12	抗衰老药物制剂
HK19101111.1A HK1259143A1 (zh)	2016-08-17	2017-05-12	抗衰老药物制剂

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
HK18114754.7A HK1255619A1 (zh)	2016-08-17	2017-05-12	抗衰老药物制剂
HK19101111.1A HK1259143A1 (zh)	2016-08-17	2017-05-12	抗衰老药物制剂

Country Status (21)

Country	Link
US (3)	US20190290689A1 (zh)
EP (4)	EP3352769A1 (zh)
JP (2)	JP2019528281A (zh)
KR (2)	KR20190049690A (zh)
CN (2)	CN108348548A (zh)
AU (2)	AU2017313163B2 (zh)
BR (1)	BR112019002982A2 (zh)
CA (2)	CA3033045A1 (zh)
CL (2)	CL2019000419A1 (zh)
CO (2)	CO2019001232A2 (zh)
CR (2)	CR20190139A (zh)
EA (2)	EA201890841A1 (zh)
HK (3)	HK1258712A1 (zh)
IL (2)	IL259007B2 (zh)
MA (2)	MA42963A (zh)
MX (2)	MX2019001948A (zh)
PE (2)	PE20190627A1 (zh)
PH (2)	PH12019550017A1 (zh)
SG (2)	SG11201900866YA (zh)
TW (2)	TW201806605A (zh)
WO (3)	WO2018033226A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3352769A1 (en) *	2016-08-17	2018-08-01	Orthogen AG	Anti-ageing pharmaceutical preparation
CN108841784A (zh) *	2018-07-17	2018-11-20	温州医科大学附属第二医院、温州医科大学附属育英儿童医院	一种含黄芪甲苷的髓核细胞抗衰老抗凋亡培养基
EP3613424A1 (en)	2018-08-23	2020-02-26	Orthogen AG	Novel methods for the production of pharmaceutical agents
RU2695264C1 (ru) *	2018-12-27	2019-07-22	федеральное государственное бюджетное образовательное учреждение высшего образования "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВО ХГУ им. Н.Ф. Катанова)	Способ прогнозирования ускоренного старения организма женщин, основанный на клинических данных о состоянии репродуктивной функции
US20220062159A1 (en) *	2018-12-27	2022-03-03	Suntory Holdings Limited	Agent for inhibiting reduction in decomposition of denatured elastin, agent for maintaining normal elastin fibers, agent for inhibiting formation of elastin-elafine composite, and screening method for substance having elastin-elafine composite formation inhibitory effect
EP3845566A1 (en)	2019-12-30	2021-07-07	Industrial Technology Research Institute	Extracellular vesicle separation method, colloidal particle and preparation method thereof
US12077780B2 (en)	2020-02-14	2024-09-03	Allergan Sales, Llc	Conditioned medium from cells cultured under hypoxic conditions and uses thereof
TW202448491A (zh) *	2022-05-16	2024-12-16	台灣粒線體應用技術股份有限公司	組合物及其用於減緩口腔損傷的用途
JP7624256B1 (ja)	2024-01-26	2025-01-30	万里坂井	医薬組成物及びその製造方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20060116321A1 (en) *	2004-07-01	2006-06-01	Robbins Paul D	Immunosuppressive exosomes
DE102006005016A1 (de) *	2006-02-03	2007-08-16	Orthogen Ag	Konditionierte Blutzusammensetzung und Verfahren zu deren Herstellung
DE202009017772U1 (de) *	2009-12-10	2011-04-21	Orthogen Ag	Kombinationspräparate mit Cytokin-Antagonist und Corticosteroid
WO2012076193A1 (de) *	2010-12-10	2012-06-14	Orthogen Ag	Kombinationspräparate mit exosomen und corticosteroid
WO2014028493A2 (en) *	2012-08-13	2014-02-20	Cedars-Sinai Medical Center	Exosomes and micro-ribonucleic acids for tissue regeneration
DE102012019088A1 (de) *	2012-09-28	2014-04-03	Orthogen Ag	Antibakterielle Arzneimittelpräparate
CN103767985A (zh) *	2012-10-22	2014-05-07	吉林省霍普金斯药物研究院有限责任公司	人源血液或间充质干细胞分泌exosome的制备与应用
KR101784050B1 (ko) *	2014-12-23	2017-10-10	영남대학교 산학협력단	엑소솜을 유효성분으로 함유하는 피부 노화 예방 또는 치료용 약학조성물
TW201722443A (zh) *	2015-11-13	2017-07-01	奧爾托金公司	對老化相關病症有效之醫藥製劑
CN105477016A (zh) *	2015-11-13	2016-04-13	中国人民解放军第二军医大学	人间充质干细胞来源的外泌体在抗组织纤维化及瘢痕形成中的应用
CN105505854B (zh) *	2016-01-14	2019-07-12	上海市第六人民医院	来源于人尿液细胞的外泌体的获取方法与应用
CN105582576B (zh) *	2016-02-23	2018-08-17	武汉大复生物科技有限公司	提高内皮祖细胞外泌体释放并促进骨缺损修复的生物材料、制备方法及用途
EP3352769A1 (en) *	2016-08-17	2018-08-01	Orthogen AG	Anti-ageing pharmaceutical preparation

2017
- 2017-05-11 EP EP17728051.8A patent/EP3352769A1/en not_active Withdrawn
- 2017-05-11 HK HK19101113.9A patent/HK1258712A1/zh unknown
- 2017-05-11 US US16/325,870 patent/US20190290689A1/en not_active Abandoned
- 2017-05-11 MA MA042963A patent/MA42963A/fr unknown
- 2017-05-11 JP JP2019508969A patent/JP2019528281A/ja active Pending
- 2017-05-11 CN CN201780003804.9A patent/CN108348548A/zh active Pending
- 2017-05-11 IL IL259007A patent/IL259007B2/en unknown
- 2017-05-11 MX MX2019001948A patent/MX2019001948A/es unknown
- 2017-05-11 WO PCT/EP2017/000574 patent/WO2018033226A1/en not_active Ceased
- 2017-05-11 KR KR1020197003441A patent/KR20190049690A/ko not_active Ceased
- 2017-05-11 EA EA201890841A patent/EA201890841A1/ru unknown
- 2017-05-11 EP EP20155846.7A patent/EP3695845A1/en active Pending
- 2017-05-11 CR CR20190139A patent/CR20190139A/es unknown
- 2017-05-11 PE PE2019000304A patent/PE20190627A1/es not_active Application Discontinuation
- 2017-05-11 AU AU2017313163A patent/AU2017313163B2/en active Active
- 2017-05-11 SG SG11201900866YA patent/SG11201900866YA/en unknown
- 2017-05-11 CA CA3033045A patent/CA3033045A1/en active Pending
- 2017-05-12 TW TW106115815A patent/TW201806605A/zh unknown
- 2017-05-12 US US16/325,945 patent/US20210290671A1/en not_active Abandoned
- 2017-05-12 EP EP20163717.0A patent/EP3763377A1/en not_active Withdrawn
- 2017-05-12 HK HK18114754.7A patent/HK1255619A1/zh unknown
- 2017-05-12 MA MA042964A patent/MA42964A/fr unknown
- 2017-05-12 AU AU2017313164A patent/AU2017313164B2/en active Active
- 2017-05-12 JP JP2019508931A patent/JP2019529357A/ja active Pending
- 2017-05-12 EA EA201890840A patent/EA201890840A1/ru unknown
- 2017-05-12 CR CR20190091A patent/CR20190091A/es unknown
- 2017-05-12 TW TW106115816A patent/TW201806606A/zh unknown
- 2017-05-12 MX MX2019001949A patent/MX2019001949A/es unknown
- 2017-05-12 SG SG11201901085RA patent/SG11201901085RA/en unknown
- 2017-05-12 HK HK19101111.1A patent/HK1259143A1/zh unknown
- 2017-05-12 CA CA3033899A patent/CA3033899A1/en not_active Abandoned
- 2017-05-12 KR KR1020197004442A patent/KR20190046793A/ko not_active Withdrawn
- 2017-05-12 CN CN201780003805.3A patent/CN108348549A/zh active Pending
- 2017-05-12 WO PCT/EP2017/000581 patent/WO2018033227A1/en not_active Ceased
- 2017-05-12 BR BR112019002982-6A patent/BR112019002982A2/pt not_active Application Discontinuation
- 2017-05-12 EP EP17728052.6A patent/EP3352770A1/en not_active Withdrawn
- 2017-05-12 PE PE2019000361A patent/PE20190517A1/es not_active Application Discontinuation
- 2017-08-17 WO PCT/EP2017/000994 patent/WO2018033249A1/en not_active Ceased
- 2017-08-17 US US16/325,944 patent/US20190231816A1/en not_active Abandoned
2018
- 2018-04-29 IL IL259006A patent/IL259006A/en unknown
2019
- 2019-01-30 PH PH12019550017A patent/PH12019550017A1/en unknown
- 2019-02-08 PH PH12019550022A patent/PH12019550022A1/en unknown
- 2019-02-12 CO CONC2019/0001232A patent/CO2019001232A2/es unknown
- 2019-02-13 CO CONC2019/0001265A patent/CO2019001265A2/es unknown
- 2019-02-15 CL CL2019000419A patent/CL2019000419A1/es unknown
- 2019-02-15 CL CL2019000420A patent/CL2019000420A1/es unknown

Also Published As

Publication number	Publication date
EP3352770A1 (en)	2018-08-01
MA42964A (fr)	2018-08-01
TW201806605A (zh)	2018-03-01
PH12019550022A1 (en)	2019-12-02
KR20190049690A (ko)	2019-05-09
EA201890841A1 (ru)	2018-09-28
BR112019002982A2 (pt)	2019-05-14
WO2018033227A8 (en)	2019-01-24
AU2017313163B2 (en)	2019-01-03
HK1255619A1 (zh)	2019-08-23
CL2019000419A1 (es)	2019-07-05
WO2018033226A1 (en)	2018-02-22
CR20190139A (es)	2019-06-03
AU2017313163A1 (en)	2018-05-10
CR20190091A (es)	2019-05-07
MX2019001949A (es)	2019-05-15
CL2019000420A1 (es)	2019-07-05
CN108348548A (zh)	2018-07-31
JP2019528281A (ja)	2019-10-10
TW201806606A (zh)	2018-03-01
PE20190517A1 (es)	2019-04-10
HK1259143A1 (zh)	2019-11-29
CO2019001232A2 (es)	2019-02-28
MA42963A (fr)	2018-08-01
IL259007B1 (en)	2024-03-01
SG11201901085RA (en)	2019-03-28
CO2019001265A2 (es)	2019-02-28
CA3033045A1 (en)	2018-02-22
IL259006A (en)	2018-07-31
PE20190627A1 (es)	2019-04-26
PH12019550017A1 (en)	2019-11-04
BR112019002080A2 (pt)	2019-05-14
CN108348549A (zh)	2018-07-31
CA3033899A1 (en)	2018-02-22
AU2017313164B2 (en)	2019-01-03
IL259007A (en)	2018-07-31
SG11201900866YA (en)	2019-02-27
US20190231816A1 (en)	2019-08-01
WO2018033227A1 (en)	2018-02-22
WO2018033249A1 (en)	2018-02-22
IL259007B2 (en)	2024-07-01
EP3695845A1 (en)	2020-08-19
JP2019529357A (ja)	2019-10-17
US20190290689A1 (en)	2019-09-26
KR20190046793A (ko)	2019-05-07
EP3352769A1 (en)	2018-08-01
AU2017313164A1 (en)	2018-05-10
US20210290671A1 (en)	2021-09-23
MX2019001948A (es)	2019-05-15
EA201890840A1 (ru)	2018-09-28
EP3763377A1 (en)	2021-01-13

Publication	Publication Date	Title
HK1259143A1 (zh)	2019-11-29	抗衰老药物制剂
EP4300070A3 (en)	2024-04-10	Culture patch, culture method, method and apparatus for testing culture, and method and apparatus for testing medicine
WO2013036863A3 (en)	2013-07-11	Efficient use of ionic liquids
WO2013096838A3 (en)	2015-06-18	Systems and methods for isolating nucleic acids
MX2017015758A (es)	2019-04-15	Componente de dispositivo, dispositivo, y metodo para purificar y ensayar biomoleculas de muestras biologicas.
EP4556576A3 (en)	2025-08-06	Methods to diagnose and treat acute respiratory infections
MX342218B (es)	2016-09-21	Dispositivo analitico.
WO2016012459A3 (en)	2016-03-24	Parallel cell processing method and facility
WO2012107841A3 (en)	2013-01-17	Micro -rna biomarkers for identifying risk of and/or for diagnosing lung tumour and pharmaceutical compositions thereof
EA201792538A1 (ru)	2018-06-29	Способ биологического получения метакриловой кислоты
WO2012082678A3 (en)	2014-04-24	Tissue processor
TW201614109A (en)	2016-04-16	Method and apparatus for cleaning wire rod
EP2647643A3 (en)	2014-03-12	Procedure for the purification of tiacumicin B
CA2982706A1 (en)	2016-12-15	Automatable method for nucleic acid isolation
EP3161165A4 (en)	2018-01-24	Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets
MX2015007494A (es)	2015-12-15	Metodo para diagnosticar leucodistrofia metacromatica.
SG11202104757YA (en)	2021-06-29	Membrane for separation of stem cells from biological samples, production process of said membrane, and process and device for separation, comprising said membrane
EP3186624A4 (en)	2018-03-28	Apparatus and method for detection and quantification of biological and chemical analytes
WO2013019977A3 (en)	2013-04-18	Extraction, purification, and processing of phytoglycogen
WO2014176167A3 (en)	2014-12-31	Drug concentration from an oral fluid
WO2016023612A8 (de)	2017-02-02	Petrischale und verfahren zur mikrobiologischen untersuchung von flüssigkeiten mittels membranfiltration
WO2013122611A3 (en)	2014-04-24	New method for decontamination and processing of clinical specimens from a patient
MY180705A (en)	2020-12-07	Method for producing sugar solution
WO2014064542A3 (en)	2014-06-19	Micro-scale liquid-liquid-liquid extraction
GUO et al.	2014	Quantitative measurement of sialic acid from lipoproteins by liquid chromatography tandem mass spectrometry